Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

4.4K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

330
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
330
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

691
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
691
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

568
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
568
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

552
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
552
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

585
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
585

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The paradigm shift in corticosteroid therapy for idiopathic pericarditis: from high-dose regimens to precision therapy.

Clinical and experimental rheumatology·2026
Same author

Hydroxychloroquine for recurrent pericarditis.

European journal of internal medicine·2026
Same author

Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial Diseases.

European journal of heart failure·2026
Same author

Perspective on Corticosteroid Use and Interleukin-1 Inhibition With Anakinra in Pericarditis During Pregnancy.

JACC. Advances·2026
Same author

Hydroxychloroquine for recurrent pericarditis: A multicentre observational study.

European journal of internal medicine·2026
Same author

ST-segment elevation in acute pericarditis and myocardial involvement: electrocardiographic and clinical profiling.

Open heart·2026

Related Experiment Video

Updated: Apr 15, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K

Colchicine for pericarditis: hype or hope?

Massimo Imazio1, Antonio Brucato, Rita Trinchero

  • 1Cardiology Department, Maria Vittoria Hospital, Torino, Italy. massimo_imazio@yahoo.it

European Heart Journal
|February 5, 2009
PubMed
Summary

Colchicine is safe and effective for preventing recurrent pericarditis when precautions are followed. Evidence for treating acute pericarditis is less robust, requiring further research.

More Related Videos

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

3.1K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

Related Experiment Videos

Last Updated: Apr 15, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

9.0K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

3.1K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Colchicine is recognized for treating inflammatory conditions like gout and familial Mediterranean fever.
  • Its application in pericarditis, both acute and recurrent, is gaining attention, but clinical skepticism and safety concerns persist.

Purpose of the Study:

  • To review current evidence on colchicine's efficacy and safety in treating and preventing pericarditis.
  • To address clinician skepticism regarding colchicine's benefits and tolerability.
  • To provide guidance on dosing and precautions for clinical use.

Main Methods:

  • Systematic review of existing literature on colchicine for pericarditis.
  • Analysis of evidence for efficacy in acute and recurrent pericarditis.
  • Evaluation of safety, side effects, and drug interactions.

Main Results:

  • Colchicine demonstrates safety and utility in managing recurrent pericarditis with appropriate precautions.
  • Evidence supporting colchicine for acute pericarditis treatment is limited, positioning it as an optional therapy.
  • Further multicenter studies are needed to confirm its role in acute pericarditis.

Conclusions:

  • Colchicine is a valuable and safe option for recurrent pericarditis when used cautiously.
  • Its role in acute pericarditis requires more extensive investigation.
  • Clinical use should adhere to specific dosing and safety guidelines.